{"entity":{"id":"nct06980480","kind":"trial","name":"A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma","aka":[],"tldr":"A phase 3 trial of IGI, 10% in multiple myeloma, run by Takeda, now recruiting.","summary":"A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma is a phase 3 interventional study registered as NCT06980480 by Takeda, with 183 participants planned, started 2026-01-14 and due to reach its primary completion in 2028-09-11. Interventions recorded: IGI, 10%.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT06980480","url":"https://clinicaltrials.gov/study/NCT06980480"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["multiple-myeloma"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":["takeda"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06980480","phase":"3","setting":"A Multicenter, Randomized, Controlled, Open-label, Group-Sequential, Phase 3 Study to Investigate the Efficacy, Safety, and Tolerability of Intravenous Gammagard Liquid (Immune Globulin Infusion, 10%) for Primary Infection Prophylaxis Compared With Secondary Infection Prophylaxis in Adult Subjects With Multiple Myeloma Receiving B-Cell Maturation AntigenxCD3-Directed Bispecific Antibody Therapy","sponsor":"Takeda","participation":[{"nct":"NCT06980480","source":"https://clinicaltrials.gov/study/NCT06980480","fetchedAt":"2026-10-07T16:55:20.203Z","studySha256":"875805c7419397820c2cf53fe03273608662f589d5b9b412194db15155df338f","overallStatus":"RECRUITING","lastUpdatePosted":"2026-09-09","leadSponsor":"Takeda","collaboratorCount":2,"minimumAge":"18 Years","sex":"ALL","healthyVolunteers":false,"hasEligibility":true,"enrolment":183,"enrolmentType":"ESTIMATED","siteCount":56,"recruitingSiteCount":56,"countries":["Australia","Austria","Brazil","Canada","Czechia","Denmark","Greece","Hungary","Italy","Netherlands","Norway","Poland","Romania","Spain","United Kingdom","United States"]}],"started":"2026-01-14","startedType":"actual","enrolled":183,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06980480/","neighbours":{"cancer":[{"id":"multiple-myeloma","kind":"cancer","name":"Multiple myeloma","route":"/cancers/multiple-myeloma/"}],"company":[{"id":"takeda","kind":"company","name":"Takeda","route":"/companies/takeda/"}]}}